Recent Updates
Recently added Catalysts
GRAL Positive Sentiment Score: 80/100

GRAIL Appoints Sarah Krevans to Board of Directors GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the appointment of...

Key Takeaway: GRAIL, Inc. has appointed Sarah Krevans to its Board of Directors, effective immediately. Krevans, who previously served as president and CEO of Sutter Health, brings extensive experience in healthcare leadership. She will also be a member of several Board Committees, including Audit, Compensation, and Nominating and Governance. CEO Bob Ragusa expresses confidence in Krevans' ability to enhance GRAIL's mission of early cancer detection as the company seeks to establish new standards of care.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of an experienced leader to the Board of Directors.
  • Sarah Krevans' background in healthcare leadership at Sutter Health.
  • Confidence expressed by GRAIL CEO Bob Ragusa regarding Krevans’ potential impact.

Full Press Release Details

MENLO PARK, Calif. , Oct. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL ), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the appointment of Sarah Krevans to its Board of Directors, effective immediately. Ms. Krevans will also serve as a member of the Board's Audit Committee, Compensation Committee, and Nominating and Governance Committee. Following the appointment of Ms. Krevans, the Board will be composed of five directors, four of whom are independent.
Ms. Krevans served as president and CEO of Sutter Health, a Northern California based not-for-profit health system in one of the most diverse and innovative regions in the nation, from 2016 to 2022. She was responsible for Sutter Health's integrated network of 14,000 clinicians, 24 hospitals, outpatient services, research facilities, and home health and hospice care. Under her leadership, Ms. Krevans advanced clinical programs, innovation, and digital health to make healthcare more accessible for patients.
"Sarah is a highly accomplished healthcare leader with extensive experience in a dynamic and diverse environment," said Bob Ragusa , CEO of GRAIL. "I am confident that her experience will bring immense value to GRAIL as we move toward establishing a new standard of care for multi-cancer early detection for patients."
Previously, Ms. Krevans served as chief operating officer, and regional executive officer and president of the Sutter Health Sacramento Sierra Region. She also held executive roles at Kaiser Permanente and served as deputy director of Maine's Bureau of Medical Services and acting director of Medicaid, health planning and licensure programs. Ms. Krevans' experience as a board member includes serving on many not-for-profit boards and as Chair of the California Association of Hospitals. She currently serves on the board of the Acacium Group and is the incoming Chair of CaringBridge.
Ms. Krevans earned master's degrees in business administration and in public health from the University of California, Berkeley , and a bachelor's degree from Boston University . She has been named as one of the "Top 25 Women Leaders" by Modern Healthcare and included on Modern Healthcare's list of the "100 Most Influential People in Healthcare."
For more information, visit grail.com .
SOURCE GRAIL, Inc.

21 %

Frequently Asked Questions

Who was appointed to GRAIL's Board of Directors?

Sarah Krevans has been appointed to GRAIL's Board of Directors.

What committees will Sarah Krevans serve on?

She will serve on the Audit, Compensation, and Nominating Committees.

What role did Krevans hold before joining GRAIL?

She was the president and CEO of Sutter Health from 2016 to 2022.

How many directors are on GRAIL's Board now?

The Board now comprises five directors, with four being independent.

Where did Krevans earn her master's degrees?

She earned her master's degrees from the University of California, Berkeley.

Last updated: Oct 21, 2024